The effect of Bozungikgitang on the fatigue, and general weakness in the postoperative thyroid cancer patients receiving thyroid hormone replacement therapy

Not Applicable

Recruiting

• Conditions: Not Applicable

• Registration Number: KCT0001414
• Lead Sponsor: Daegu Catholic Univercity Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

? subject to target patients underwent total thyroidectomy.
? surgery despite taking of thyroid hormones received thyroid papillary carcinoma, and fatigue in patients complained least three months.
? And at the age of between19 ~80 years of age in patients .

Exclusion Criteria

? if the patient does not agree with this study is excluded from the study.
? The age of patients less than 19 years old, 80 years of age or older, with the exception of the case.
? systemic symptoms if administered by a non-defective bojung ikgitang are excluded.
? person participating in another clinical studies excluded.
? pregnant women, nursing mothers, women of childbearing age are excluded unless adequate contraception.
? thyroid function test abnormal hormone levels, factors are excluded.
(Free T4 is abnormal while excluding subjects of TSH <0.1, or TSH> 5 )

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
fatigue scale

Secondary Outcome Measures

Name	Time	Method
8-hydroxy-2’-deoxyguanosine (8-OHdG), EORTC-QoL questaionnaire